HbA1c

Your HbA1c (hemoglobin A1c, also called glycated hemoglobin) is one of the most important numbers in metabolic health. While a fasting glucose test captures a single moment, HbA1c tells you what your blood sugar has been doing on average over the past two to three months. It is the primary tool used to diagnose prediabetes and diabetes and the standard metric for monitoring glucose control over time.

The test works because glucose in your blood naturally attaches to hemoglobin, the oxygen-carrying protein inside red blood cells. The more glucose circulating in your blood, the more hemoglobin gets coated. Since red blood cells live for about 120 days, measuring how much of your hemoglobin is sugar-coated gives a weighted average of your glucose exposure, with more recent weeks contributing more heavily than earlier ones. In healthy individuals, HbA1c makes up about 5% of total hemoglobin.

What Your Number Means

HbA1c offers practical advantages over glucose testing: you do not need to fast, it is less affected by day-to-day fluctuations from stress, illness, or a single meal, and it has greater stability in the lab. These features make it both a diagnostic test and a monitoring tool.

What this means for you: if your HbA1c falls in the prediabetes range, the relationship between this number and future diabetes is not a cliff but a steep slope. Every tenth of a percent matters. An HbA1c of 6.3% carries substantially more risk than 5.8%, even though both carry the same label. This is a space where early intervention has the highest return.

When HbA1c Can Mislead You

Because HbA1c depends on hemoglobin and red blood cell lifespan, anything that alters either one can skew the result. Several conditions can make your HbA1c read falsely low, suggesting better control than you actually have:

• Conditions that shorten red blood cell life: hemolytic anemia, significant blood loss, an enlarged spleen, erythropoietin therapy, or recent blood transfusion. When red blood cells are destroyed or replaced faster than normal, there is less time for glucose to accumulate on hemoglobin.
• Pregnancy: in the second and third trimesters, HbA1c tends to underestimate true glucose exposure.
• Chronic kidney disease and advanced liver disease: both can alter red blood cell dynamics enough to lower the reading.

Conversely, iron deficiency anemia can make HbA1c read falsely high, because red blood cells circulate longer when iron is scarce, giving glucose more time to attach. Severe hypertriglyceridemia, elevated bilirubin, and chronic alcohol use can also push the number upward.

For people with certain hemoglobin variants (such as homozygous sickle cell disease), HbA1c cannot be measured at all because the hemoglobin A that the test detects is absent. In these situations, alternative markers like fructosamine or glycated albumin, which reflect glucose control over a shorter window of about 2 to 3 weeks, can be used instead.

HbA1c also has an inherent blind spot: it reveals nothing about glucose variability or low blood sugar episodes. Two people with an identical HbA1c of 7.0% might have very different daily glucose patterns. One might hold steady between 130 and 150 mg/dL all day, while the other swings between 50 and 250 mg/dL. Continuous glucose monitoring (CGM) fills this gap. Time in range (the percentage of the day spent between 70 and 180 mg/dL) has emerged as a powerful complementary metric. A time in range above 70% correlates with an HbA1c of approximately 7% and is independently associated with reduced risk of kidney damage, eye disease, and cardiovascular mortality.

What Moves This Biomarker

Because HbA1c reflects average glucose over months, it responds to sustained changes rather than day-to-day fluctuations. Anything that consistently lowers your blood sugar will improve your HbA1c over the next testing cycle.

Weight loss and dietary change remain the most effective lifestyle interventions. The Diabetes Prevention Program demonstrated that 7% weight loss combined with 150 minutes of weekly exercise reduced diabetes incidence by 58%. The Mediterranean diet improves glycemic control even without caloric restriction.

Regular physical activity of at least 150 minutes per week of moderate intensity improves insulin sensitivity and glucose uptake, lowering average glucose and thereby HbA1c.

Medications each lower HbA1c by characteristic amounts: metformin by up to 2.0%, SGLT2 inhibitors by 0.5 to 1.0%, GLP-1 receptor agonists by 0.5 to 1.5%, and DPP-4 inhibitors by up to 1.0%. CGM itself has been shown to lower HbA1c by a mean of 0.31% compared to traditional finger-stick monitoring, likely by helping people make real-time adjustments to food, activity, and medication.

Questions This Biomarker Can Answer

• What has my average blood sugar been over the past two to three months?
• Am I in the prediabetes range, and how steep is my trajectory toward diabetes?
• Is my current treatment plan keeping my glucose control in a range that reduces my risk of complications?
• Am I at the right HbA1c target for my age, health status, and medication risk profile, or should my goal be adjusted?
• Do I need complementary monitoring like continuous glucose tracking to understand my glucose variability, which HbA1c alone cannot reveal?